Related Experiment Video
Updated: Apr 12, 2026

Isolation and Functional Characterization of Human Ventricular Cardiomyocytes from Fresh Surgical Samples
Published on: April 21, 2014
Atrial and ventricular arrhythmias in hypertrophic cardiomyopathy
Kartik R Kumar1, Swati N Mandleywala1, Mark S Link1
1Department of Cardiology, Tufts Medical Center, 800 Washington Street, Boston, MA 02111, USA.
Insights
Hypertrophic cardiomyopathy (HCM), a common inherited heart disease, stems from genetic mutations. It increases the risk of serious arrhythmias, complicating patient management and impacting outcomes.
Area of Science:
- Cardiology
- Genetics
- Inherited Diseases
Background:
- Hypertrophic cardiomyopathy (HCM) is the most prevalent inherited cardiac condition, affecting 0.2% of the population.
- It is an autosomal dominant disorder resulting from mutations in genes encoding cardiac sarcomeres.
- HCM presents with diverse clinical features, including myocardial disarray and hypertrophy.
Purpose of the Study:
- To summarize the genetic basis and clinical implications of hypertrophic cardiomyopathy.
- To highlight the increased risk of arrhythmias in HCM patients.
- To discuss the complexities in managing these cardiac arrhythmias.
Main Methods:
- Review of genetic and clinical literature on hypertrophic cardiomyopathy.
- Analysis of prevalence and inheritance patterns.
- Summary of arrhythmogenic risks and management strategies.
Main Results:
- HCM is caused by various genetic variants leading to myocardial hypertrophy and disarray.
- Patients with HCM face a higher risk of both atrial and ventricular arrhythmias.
- Atrial fibrillation correlates with elevated mortality and thromboembolism risk.
Conclusions:
- Effective management of arrhythmias in HCM is crucial due to associated risks.
- Ventricular arrhythmias pose a life-threatening risk, often necessitating implantable defibrillators.
- Understanding the genetic underpinnings of HCM is key to improving patient care and outcomes.
Abstract:
Hypertrophic cardiomyopathy (HCM) is an autosomal dominant disease caused by mutations in genes coding for cardiac sarcomeres. HCM is the most common inherited heart disease, with a prevalence of 0.2%. There are multiple genetic variants that cause pleomorphic clinical attributes and disease characterized by myocardial disarray and myocardial hypertrophy. Patients are at an increased risk of atrial and ventricular arrhythmias. Management of these arrhythmias is complex. Atrial fibrillation is associated with increased mortality and thromboembolism. Ventricular arrhythmias are life threatening and best treated with an implantable defibrillator.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Mechanism of Cardiac Arrhythmias
Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Dysrhythmias III: Characteristics of Dysrhythmias
Cardiomyopathy I: Introduction and Classification

